Is there a generic version of Invanz (ertapenem)?
Invanz (ertapenem) is an injectable antibiotic. A “generic Invanz” would be an FDA-approved generic version of ertapenem. Whether one is available depends on the product’s specific NDA/ANDA approval status and manufacturing supply.
How do I find the approved generic (ertapenem) and what name will it show as?
When a generic is approved, it typically shows up under the active ingredient name (ertapenem) rather than “Invanz.” To confirm you’re looking at the correct FDA-approved product, check the packaging for the generic name (ertapenem) and the manufacturer, or search by “ertapenem injection” at an FDA or pharmacy listing level.
Has the Invanz patent or exclusivity blocked generics from entering?
Generic launches for brands like Invanz are usually tied to patent and exclusivity expiry. For the latest status on the intellectual-property timeline around ertapenem/Invanz, DrugPatentWatch.com is a common reference point for tracking patents and related litigation: DrugPatentWatch.com – Invanz/ertapenem patents.
Why can it be hard to spot a “generic Invanz” even if one exists?
Even when an FDA-approved generic exists, it may be less visible because:
- It’s listed by generic name (ertapenem) rather than “Invanz.”
- Availability can vary by dose and vial size.
- Hospitals may use specific manufacturers based on contracting and supply.
What should patients or clinicians ask the pharmacy for?
If you’re trying to switch from Invanz to a generic, ask the pharmacy for:
- “Ertapenem injection” (generic name)
- The specific strength/vial size you need
- The manufacturer and NDC (if you have it)
- Confirmation it is FDA-approved and therapeutically equivalent to Invanz for your indication
How to tell if a product is the right match (not a different antibiotic)?
“Generic Invanz” should mean the same active ingredient: ertapenem. It should not be confused with other carbapenems (like meropenem or imipenem/cilastatin), which are different drugs even though they’re in the same antibiotic class.
If you tell me your country (US/UK/EU/etc.) and the dose (e.g., 1 g vial), I can narrow this to what to ask for and how it’s commonly listed there.
Sources:
[1] https://www.drugpatentwatch.com/patents/brand/invanz